A third dose of the COVID-19 vaccine from Pfizer Inc. and BioNTech was found in a large study to be highly protective against symptomatic COVID-19, the companies said Thursday.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
